U.S. markets closed

Conatus: 4Q Earnings Snapshot

SAN DIEGO (AP) _ Conatus Pharmaceuticals Inc. (CNAT) on Wednesday reported a loss of $2.7 million in its fourth quarter.

The San Diego-based company said it had a loss of 8 cents per share.

The biotechnology company posted revenue of $526,000 in the period.

For the year, the company reported that its loss narrowed to $11.4 million, or 34 cents per share. Revenue was reported as $21.7 million.

In the final minutes of trading on Wednesday, the company's shares hit 34 cents. A year ago, they were trading at $2.10.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CNAT at https://www.zacks.com/ap/CNAT